Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| F174B | Q3ZCQ3 | Membrane protein FAM174B | Predicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 1 | 0.53 | |||
| FCAR | P24071 | Immunoglobulin alpha Fc receptor (IgA Fc receptor) (CD antigen CD89) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 1 | Diabetes mellitus | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| FCG2A | P12318 | Low affinity immunoglobulin gamma Fc region receptor II-a (IgG Fc receptor II-a) (CDw32) (Fc-gamma RII-a) (Fc-gamma-RIIa) (FcRII-a) (CD antigen CD32) | CD markersFDA approved drug targetsHuman disease related genes | 1 | Chronic kidney diseaseLupus erythematosusThrombocytopenia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| FCG2B | P31994 | Low affinity immunoglobulin gamma Fc region receptor II-b (IgG Fc receptor II-b) (CDw32) (Fc-gamma RII-b) (Fc-gamma-RIIb) (FcRII-b) (CD antigen CD32) | Cancer-related genesCD markersDisease related genes | 1 | Systemic lupus erythematosusAutoimmune diseaseB-cell lymphoma | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| FCG3A | P08637 | Low affinity immunoglobulin gamma Fc region receptor III-A (IgG Fc receptor III-A) (CD16-II) (CD16a antigen) (Fc-gamma RIII-alpha) (Fc-gamma RIII) (Fc-gamma RIIIa) (FcRIII) (FcRIIIa) (FcgammaRIIIA) (FcR-10) (IgG Fc receptor III-2) (CD antigen CD16a) | CD markersDisease related genesFDA approved drug targets | 1 | Hodgkin lymphomaLymphomaMature T-cell lymphoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| FCGR1 | P12314 | High affinity immunoglobulin gamma Fc receptor I (IgG Fc receptor I) (Fc-gamma RI) (FcRI) (Fc-gamma RIA) (FcgammaRIa) (CD antigen CD64) | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||||
| FCGRN | P55899 | IgG receptor FcRn large subunit p51 (FcRn) (IgG Fc fragment receptor transporter alpha chain) (Neonatal Fc receptor) | FDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins | 1 | Acquired haemolytic anaemiaIdiopathic inflammatory myopathyInflammatory polyneuropathy | Clinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| FCRL3 | Q96P31 | Fc receptor-like protein 3 (FcR-like protein 3) (FcRL3) (Fc receptor homolog 3) (FcRH3) (IFGP family protein 3) (hIFGP3) (Immune receptor translocation-associated protein 3) (MAIA) (SH2 domain-containing phosphatase anchor protein 2) (CD antigen CD307c) | CD markersDisease related genesPredicted intracellular proteins | 1 | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.53 | |||
| FGFR1 | P11362 | Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331) | Cancer-related genesCD markersDisease related genes | 1 | CraniosynostosisDwarfismHoloprosencephaly | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| FGFR2 | P21802 | Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332) | Cancer-related genesCD markersDisease related genes | 1 | CraniosynostosisEctodermal dysplasiaIntellectual disability | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 |